StockData
YD Bio Ltd logo

YD Bio Ltd (YDES) stock

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30
$4.88−0.32 (-6.06%)

Close on Nov 13, 2026Market cap $345.45MP/E –Yield –

YD Bio statistics

78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$345.45M
$1.68B
Enterprise Value
$342.79M
$2.20B
PS Ratio
578.82
1.53
PB Ratio
77.21
3.46
P/TBV Ratio
172.70
5.80

Enterprise valuationIndustry

EV / Sales
574.36
1.67

Share statisticsIndustry

Shares Change (YoY)
3.07%
2.40%
Float
5M
34M
Shares Held by Insiders
92.8%
15.4%

Short sellingIndustry

Short Interest
187,405
–
Short Interest Change
-2.51%
-0.86%
Days to Cover
1.50
4.41

Stock price statisticsIndustry

52-Week High
$15.72
–
52-Week Low
$1.70
–
20-Day Moving Average
$5.89
–
50-Day Moving Average
$5.51
–
200-Day Moving Average
$5.24
–
Average True Range (14)
$0.88
–
Price Change (1 Week)
-18.3%
0.23%
Price Change (1 Month)
-27.6%
-0.02%
Price Change (3 Months)
44.8%
2.13%
Price Change (6 Months)
-5.70%
17.6%
Price Change (YTD)
-60.0%
5.22%
Price Change (1 Year)
-44.8%
3.75%
Price Change (3 Years)
-55.7%
15.2%
Price Change (5 Years)
-52.0%
-14.6%
Average Volume (10 Days)
83,308
–
Average Volume (20 Days)
103,391
–
Average Volume (90 Days)
232,555
–
Relative Volume
0.11
0.70
Relative Strength Index (14)
42.5
46.0
Volatility (1 Year)
137.5%
64.2%
Beta (5 Years)
0.10
0.76

MarginsIndustry

Gross Margin
28.1%
33.3%
Operating Margin
-883.3%
-2.98%
Pretax Margin
-1392.9%
2.12%
Profit Margin
-1392.6%
-2.01%
EBITDA Margin
-883.3%
3.36%
FCF Margin
-1346.6%
2.98%

Returns on capitalIndustry

Return on Equity (ROE)
-173.8%
4.82%
Return on Assets (ROA)
-104.5%
-3.10%
Return on Invested Capital (ROIC)
-129.5%
4.69%
Return on Capital Employed (ROCE)
-58.6%
0.40%

Financial positionIndustry

Current Ratio
5.23
1.41
Quick Ratio
2.70
0.99

GrowthIndustry

Revenue Growth (YoY)
16.9%
9.63%

EfficiencyIndustry

Asset Turnover
0.08
0.81
Inventory Turnover
0.23
10.99
Revenue Per Employee
$45.91K
$235.26K
Profits Per Employee
-$639.33K
-$5.12K
Employee Count
13
910
WACC
7.60%
8.40%

Income statement (TTM)Industry

Revenue
$596.82K
$638.13M
Gross Profit
$167.41K
$196.31M
Operating Income
-$5.27M
-$675.66K
Pretax Income
-$8.31M
-$575.82K
Net Income
-$8.31M
-$1.48M
EBITDA
-$5.27M
$1.17M
EPS (Diluted)
-$0.12
-$0.02

Balance sheetIndustry

Net Cash (Debt)
$2.66M
$203.66K
Net Cash Per Share
$0.04
$0.00
Equity (Book Value)
$4.47M
$235.60M
Book Value Per Share
$0.06
$3.91
Tangible Book Value
$2.00M
$1.59M
Working Capital
$4.52M
$30.06M

Cash flow (TTM)Industry

Operating Cash Flow
-$6.60M
$25.90M
Capital Expenditures
-$1.44M
-$15.83M
Free Cash Flow
-$8.04M
$18.83M
FCF Per Share
-$0.11
$0.36

Dividends and yieldsIndustry

Earnings Yield
-2.41%
0.19%
FCF Yield
-2.33%
2.55%
Buyback Yield
-3.82%
1.01%
Shareholder Yield
-3.82%
1.58%

Taxes and interestIndustry

Income Tax
-$1.53K
$564.50K

Scores and fair valueIndustry

Altman Z-Score
35.48
2.24
Piotroski F-Score
2
5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodYDESS&P 500DifferenceYDES per yearS&P 500 per year
1 month-20.0%-3.0%−17.0 pts
3 months+94.4%-2.8%+97.2 pts
Year to date-60.0%+11.5%−71.5 pts
1 year-51.8%+13.5%−65.2 pts
3 years-55.7%+77.7%−133.4 pts-23.8%+21.1%
5 years-52.0%+72.6%−124.6 pts-13.7%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M YDES shares were sold short on Oct 30, 2026, down 2.5% from the previous report. At recent volumes it would take 1.5 days to buy them back. Over the last 20 sessions, 47.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026187,405-2.5%124,9701.5
Oct 15, 2026192,222+8.4%203,7401.0
Sep 30, 2026177,332+312.8%728,5051.0
Sep 15, 202642,960+223.2%619,9361.0
Aug 31, 202613,293-22.6%97,7701.0
Aug 14, 202617,167+5.5%38,3321.0
Jul 31, 202616,273-35.2%31,1071.0
Jul 15, 202625,094+124.7%621,1131.0
Jun 30, 202611,169-18.4%101,0481.0
Jun 15, 202613,680-17.8%16,8441.0
May 29, 202616,646+5.5%10,2581.6
May 15, 202615,774-27.9%5,0853.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?